Abstract
Background: Currently there are no tests to assist in selecting the optimal preoperative chemotherapy (Primary Systemic Therapy, PST) regimens for breast cancer patients. Primary study goals of this prospective, single-armed multicentric investigation are pathologically confirmed tumour response and the rate of breast conserving therapy (BCT). Secondary study goals are to find histopathologic and gene profiling patterns best correlating with tumour remission in a taxane- anthracycline based neoadjuvant setting as well as to evaluate cytostatic toxicity and quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
